NCT05662540 2024-10-26
PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
Ruijin Hospital
Phase NA Recruiting
Clinical Trials
10 trialsNCT04132843 2022-11-21
Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions
M.D. Anderson Cancer Center
Phase NA Completed
NCT05090956 2021-10-25
(MISAP)
Institut National de la Santé Et de la Recherche Médicale, France
Phase NA Completed
NCT01004718 2021-05-18
Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT00544219 2019-05-15
PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Swiss Cancer Institute
Phase NA Completed
NCT00504205 2013-08-02
MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma
National Cancer Institute (NCI)
Phase NA Terminated
NCT00887718 2012-12-18
Positron Emission Tomography(PET) in Lymphoma Assessment
University Health Network, Toronto
Phase NA Completed
NCT00110006 2010-06-11
Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
Case Comprehensive Cancer Center
Phase NA Withdrawn
NCT00072488 2010-06-08
Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma
National Cancer Institute (NCI)
Phase NA Unknown
NCT00169598 2007-04-27
TEPELY
Hospices Civils de Lyon
Phase NA Unknown